Startups
Morphocell Technologies aims at transforming the treatment of severe liver diseases by the means of cell therapy. We are developing stem cell-derived engineered liver tissues to replace liver functions and treat several forms of liver disease.
Overview
Location
Canada
Total raised
$50M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 1, 2025 | Morphocell Technologies: $50 Million Series A Raised To Advance Regenerative Medicine | Morphocell Technologies has completed a $50 million Series A financing following a US$10 million extension led by Investissement Québec and CDP Venture Capital. The closing brings the total Series A raise to $50 million after the company se... |
| Morphocell Technologies | “Morphocell Technologies aims at transforming the treatment of severe liver diseases by the means of cell therapy. We are developing stem cell-derived engineered liver tissues to replace liver functions and treat several forms of liver dise... |
Reviews 0
FAQ about Morphocell Technologies
How much funding has Morphocell Technologies raised?
Morphocell Technologies has raised $50M in total across 1 funding round.
What has the press written about Morphocell Technologies?
Parsers VC has collected 3 articles mentioning Morphocell Technologies, among them “Morphocell Technologies: $50 Million Series A Raised To Advance Regenerative Medicine” (Dec 1, 2025) and “Morphocell Technologies”.
Is Morphocell Technologies still active?
Yes, Morphocell Technologies is active; its latest activity on Parsers VC dates from Dec 1, 2025.